SAB Biotherapeutics Inc. logo

SAB Biotherapeutics Inc.

SABS | NASDAQ
Chart Builder DCF Calculator
$3.49
+$0.10 (+2.95%)
Sep 22, 2026, 12:20 PM ET · Market open
Fiscal Quarter
Period Ending
Q2 2026
Jun 29, 2026
Q1 2026
Mar 30, 2026
Q4 2025
Dec 30, 2025
Q3 2025
Sep 29, 2025
Q2 2025
Jun 29, 2025
Q1 2025
Mar 30, 2025
Q4 2024
Dec 30, 2024
Q3 2024
Sep 29, 2024
Q2 2024
Jun 29, 2024
Q1 2024
Mar 30, 2024
Q4 2023
Dec 30, 2023
Q3 2023
Sep 29, 2023
Q2 2023
Jun 29, 2023
Q1 2023
Mar 30, 2023
Q4 2022
Dec 30, 2022
Q3 2022
Sep 29, 2022
Q2 2022
Jun 29, 2022
Q1 2022
Mar 30, 2022
Q4 2021
Dec 30, 2021
Q3 2021
Sep 29, 2021
Q2 2021
Jun 29, 2021
Q1 2021
Mar 30, 2021
Cash & Equivalents
8.27M 20.52M 10.5M 29.42M 3.69M 5.64M 8.9M 9.17M 17.24M 14.03M 56.57M 2.43M 7.77M 13.06M 15.05M 8.33M 16.62M 22.41M 33.21M 10.75M 10.23M 858.06K
Short-Term Investments
94.37M 86.87M 86.09M 81.46M 2.02M 7.21M 11.86M 21.23M 20.08M 30.02M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
105.35M 110.24M 46.89M 50.61M n/a n/a n/a n/a n/a 1.24M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 116.15M
Other Long-Term Assets
5.34M 5.28M 5.46M 124.07K 417.49K 449.79K 482.1K 514.41K 521.72K 554.03K 350.23K 371.19K 434K 434K 467.69K 501.39K 535.08K -1 n/a n/a n/a n/a
Receivables
1.84M 1.56M 946.78K 559.95K n/a 21.39K 54.96K 97.05K 224.92K 193.23K n/a n/a 364.12K 763.12K 5.56M 12.94M 9.61M 11.79M 8.01M 10.21M 17.11M n/a
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
3.46M 3.84M 3.51M 1.84M 3.59M 3.42M 2.98M 2.04M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 6.34M n/a n/a n/a
Total Current Assets
107.94M 112.78M 101.05M 113.28M 9.31M 16.3M 23.79M 32.54M 39.58M 46.95M 58.91M 3.13M 9.01M 15.03M 22.1M 22.18M 27.75M 36.17M 50.19M 21.91M 27.77M 1.12M
Property-Plant & Equipment
19.58M 20.17M 19.4M 19.44M 20.4M 21.37M 19.92M 20.75M 21.79M 22.63M 24.68M 24.84M 26M 27.21M 28.34M 29.82M 30.87M 31.3M 30.95M 29.22M 26.44M n/a
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
130.27M 135.69M 71.76M 70.17M 20.82M 21.82M 20.4M 21.26M 22.31M 24.42M 25.03M 25.21M 26.44M 27.64M 28.81M 30.33M 31.4M 31.3M 30.95M 29.22M 26.44M 116.15M
Total Assets
238.21M 248.47M 172.81M 183.45M 30.13M 38.12M 44.2M 53.8M 61.89M 71.37M 83.94M 28.34M 35.44M 42.67M 50.9M 52.51M 59.15M 67.47M 81.14M 51.13M 54.21M 117.27M
Account Payables
3.86M 3.54M 3.15M 2.95M 2.62M 2.52M 1.69M 1.3M 1.17M 1.24M 945.93K 1.08M 1.4M 1.44M 3.68M 5.48M 4.94M 4.98M 4.46M 4.12M 5.5M n/a
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a 114.7K 114.7K 377.84K 1.32M 1.63M 2.89M 2.94M n/a n/a n/a n/a 100K n/a 100K n/a
Short-Term Debt
641K n/a 951.37K n/a n/a 138.55K 275.85K 524.74K 615.82K 835.47K 1.05M 541.64K 784.88K 444.48K 772.67K n/a n/a n/a 1.8M 24.14K 24.14K n/a
Other Current Liabilities
n/a 386.34K 1.55M n/a n/a n/a n/a n/a 1.01M 1.28M 4.49M 4.43M 4.22M 923.16K 8.1M 7.69M 7.4M 10.18M 8.7M 187.93K 587.79K 80K
Total Current Liabilities
11.71M 9.85M 10.68M 10.79M 10.68M 9.65M 7.98M 8.82M 7.55M 8.3M 10.81M 9.21M 11.01M 13.67M 14.99M 17.1M 16.14M 18.26M 26.46M 10.47M 10.2M 80K
Long-Term Debt
4.49M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 541.64K 541.64K 541.64K n/a n/a n/a n/a 25.01K 25.01K n/a
Other Long-Term Liabilities
7.23M 6.12M 5.64M 2.38M 1.98M 1.35M 6.39M 4.08M 4.09M 6.31M 11.77M 417.1K 595.86K 238.34K 320.93K 357.52K 1.14M 2.87M 10.72M n/a n/a 7.8M
Total Long-Term Liabilities
11.72M 11.37M 10.63M 7.58M 7.44M 7.06M 10.25M 8.08M 8.22M 10.24M 15.83M 3.87M 4.72M 4.6M 4.85M 4.78M 5.9M 7.96M 16.14M 5.58M 5.76M 7.8M
Total Liabilities
23.43M 21.22M 21.32M 18.37M 18.11M 16.71M 18.23M 16.89M 15.77M 18.55M 26.64M 13.08M 15.73M 18.27M 19.85M 21.88M 22.03M 26.21M 42.59M 16.05M 15.95M 7.88M
Total Debt
5.13M 6.17M 5.95M 6.19M 6.42M 6.78M 4.67M 4.52M 5.34M 5.45M 5.91M 4.65M 5.58M 5.46M 5.93M 5.78M 6.07M 6.39M 8.52M 6.82M 6.92M n/a
Book Value
214.79M 227.25M 151.49M 165.07M 12.02M 21.41M 25.97M 36.9M 46.12M 52.82M 57.3M 15.26M 19.72M 24.4M 31.06M 30.62M 37.12M 41.26M 38.55M 35.08M 38.26M 109.39M
Book Value Per Share
2.69 4.24 3.18 2.12 1.29 2.30 2.80 3.99 4.98 5.72 9.67 2.91 3.91 4.84 6.16 7.12 8.63 9 8.87 8.07 8.80 25.16
Common Stock
8K 7.58K 4.77K 4.76K 936 936 935 929 929 929 929 5.29K 5.29K 5.09K 5.09K 4.36K 4.36K 4.35K 4.35K 3.52K 3.52K 104.39M
Retained Earnings
-152.26M -129.76M -110.9M -94.03M -139.48M -129.37M -124.17M -112.77M -102.42M -95.09M -90.06M -67.21M -62.1M -55.22M -47.87M -40M -32.92M -28.14M -29.13M -17.58M -13.52M 2.96M
Comprehensive Income
-930K -222.76K 186.51K 71.22K -15.81K -111.59K -135.41K 52.13K -31.35K -63.45K 26.42K n/a n/a n/a n/a n/a n/a n/a n/a 0 0 n/a
Shareholders Equity
214.79M 227.25M 151.49M 165.07M 12.02M 21.41M 25.97M 36.9M 46.12M 52.82M 57.3M 15.26M 19.72M 24.4M 31.06M 30.62M 37.12M 41.26M 38.55M 35.08M 38.26M 109.39M
Total Investments
199.71M 197.11M 132.98M 132.06M 2.02M 7.21M 11.86M 21.23M 20.08M 31.26M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 116.15M

© 2026 bestshares.com. All rights reserved.